Formulatrix still hopes to expand the market for digital PCR — it just might happen a little later than the company originally expected. Three years ago, the Boston-area company was gearing up to launch an inexpensive, plate-based digital PCR system called Constellation that it had hoped could bridge the gap between pricier, more complicated droplet-based digital PCR technologies and tried-and-true quantitative PCR platforms.

Source: Genomeweb

>> Read full article